Difficulty: Medium
Average Score: 87%
Testbank
A patient with severe environmental allergies is scheduled for an immunotherapy injection. What should be included in teaching the patient about this treatment?
Correct answer
B
Rationale
Patients undergoing immunotherapy injections must remain in the clinic for 30 minutes post-injection to monitor for any adverse reactions.
This monitoring period is crucial because it allows healthcare providers to observe the patient for potential allergic reactions or anaphylaxis, which can occur shortly after the injection. Immediate intervention can be life-saving if any complications arise.
A: The patient will be given a low dose of epinephrine before the treatment. This option is misleading, as epinephrine is typically reserved for emergency situations rather than a preemptive measure before immunotherapy injections.
C: Therapeutic failure occurs if the symptoms to the allergen do not decrease after 3 months. This statement oversimplifies the treatment timeline, as immunotherapy often requires longer periods, typically 6 months to a year, before assessing effectiveness.
D: The allergen will be administered by the peripheral intravenous route. This is inaccurate since immunotherapy injections are usually given subcutaneously, not through an intravenous route, which is reserved for different types of treatments.
This monitoring period is crucial because it allows healthcare providers to observe the patient for potential allergic reactions or anaphylaxis, which can occur shortly after the injection. Immediate intervention can be life-saving if any complications arise.
A: The patient will be given a low dose of epinephrine before the treatment. This option is misleading, as epinephrine is typically reserved for emergency situations rather than a preemptive measure before immunotherapy injections.
C: Therapeutic failure occurs if the symptoms to the allergen do not decrease after 3 months. This statement oversimplifies the treatment timeline, as immunotherapy often requires longer periods, typically 6 months to a year, before assessing effectiveness.
D: The allergen will be administered by the peripheral intravenous route. This is inaccurate since immunotherapy injections are usually given subcutaneously, not through an intravenous route, which is reserved for different types of treatments.